Cancer Research Cancer Medicine 8  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 4539-4546, August 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fox, S. B.
Right arrow Articles by Simmons, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, S. B.
Right arrow Articles by Simmons, D. L.

Normal Human Tissues, in Addition to Some Tumors, Express Multiple Different CD44 Isoforms

Stephen B. Fox, Jonathan Fawcett, David G. Jackson, Ian Collins, Kevin C. Gatter, Adrian L. Harris, Andrew Gearing and David L. Simmons1

Nuffield Department of Pathology, University of Oxford [S. B. F., K. C. G.], Cell Adhesion Laboratory [J. F., D. L. S.], and Molecular Oncology Unit [J. F., A. L. H.], Imperial Cancer Research Fund, Laboratories, and Molecular Immunology Group [D. G. J.], Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom; and R&D Systems Europe [I. C.] and British Biotechnology Ltd. [A. G.], Abingdon, Oxon, United Kingdom

At least 20 different isoforms of the human CD44 lymphocyte-homing receptor/hyaluronan receptor have been described to date that arise from the differential splicing of up to 10 alternative exons (termed v1–v10) encoding the membrane-proximal extracellular domain. Although numerous analyses at the mRNA level have indicated tissue-specific expression of CD44 variants, few analyses have been performed at the protein level because of limited availability of suitable monoclonal antibodies. Recently, however, exon-specific monoclonal antibodies have been generated using bacterial fusion proteins, and these have been reported to detect high levels of vCD44 containing the v6 exon on human tumors. Together with earlier evidence linking this particular exon with tumor metastasis in the rat, these latter experiments have led to the interpretation that v6 splice variants play a causative role in tumor dissemination.

In this paper we describe the use of a new and comprehensive panel of CD44 exon-specific monoclonal antibodies generated against a recombinant CD44(v3–10)-immunoglobulin chimera to study vCD44 expression in a large number of normal and neoplastic tissues. We show that the expression of vCD44 varies greatly among different human tumors and that some express either very low levels of vCD44 or no CD44 at all. Furthermore, we demonstrate that expression is not limited to isoforms containing the v6 exon but includes variants carrying v3, v4/5, and v8/9. Additionally, normal epithelial tissues are shown to express considerable levels of these same vCD44 isoforms. Such results argue against a ubiquitous role for vCD44 isoforms in promoting tumor growth and metastasis.

1 To whom requests for reprints should be addressed, at Cell Adhesion Laboratory, Imperial Cancer Research Fund, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, United Kingdom.

Received 12/28/93. Accepted 6/ 8/94.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
K A Voutilainen, M A Anttila, S M Sillanpaa, K M Ropponen, S V Saarikoski, M T Juhola, and V-M Kosma
Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer
J. Clin. Pathol., May 1, 2006; 59(5): 460 - 467.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
I. S. Lossos and D. Morgensztern
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
J. Clin. Oncol., February 20, 2006; 24(6): 995 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. K. Diaz, X. Zhou, E. T. Wright, M. Cristofanilli, T. Smith, Y. Yang, N. Sneige, A. Sahin, and M. Z. Gilcrease
CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma
Clin. Cancer Res., May 1, 2005; 11(9): 3309 - 3314.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. J. McKallip, M. Fisher, U. Gunthert, A. K. Szakal, P. S. Nagarkatti, and M. Nagarkatti
Role of CD44 and Its v7 Isoform in Staphylococcal Enterotoxin B-Induced Toxic Shock: CD44 Deficiency on Hepatic Mononuclear Cells Leads to Reduced Activation-Induced Apoptosis That Results in Increased Liver Damage
Infect. Immun., January 1, 2005; 73(1): 50 - 61.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Krettek, G. K. Sukhova, U. Schonbeck, and P. Libby
Enhanced Expression of CD44 Variants in Human Atheroma and Abdominal Aortic Aneurysm: Possible Role for a Feedback Loop in Endothelial Cells
Am. J. Pathol., November 1, 2004; 165(5): 1571 - 1581.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Sillanpaa, M. A. Anttila, K. Voutilainen, R. H. Tammi, M. I. Tammi, S. V. Saarikoski, and V.-M. Kosma
CD44 Expression Indicates Favorable Prognosis in Epithelial Ovarian Cancer
Clin. Cancer Res., November 1, 2003; 9(14): 5318 - 5324.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. P. Barbour, J. A. Reeder, M. D. Walsh, J. Fawcett, T. M. Antalis, and D. C. Gotley
Expression of the CD44v2-10 Isoform Confers a Metastatic Phenotype: Importance of the Heparan Sulfate Attachment Site CD44v3
Cancer Res., February 15, 2003; 63(4): 887 - 892.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Skoumal, G Kolarz, G Haberhauer, J Feyertag, and A Wottawa
Is soluble CD44 variant isoform 5 useful as a predicting factor and a parameter for long term observation in rheumatoid arthritis?
Ann Rheum Dis, November 1, 2002; 61(11): 1036 - 1037.
[Full Text]


Home page
Int ImmunolHome page
R. J. McKallip, Y. Do, M. T. Fisher, J. L. Robertson, P. S. Nagarkatti, and M. Nagarkatti
Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens
Int. Immunol., September 1, 2002; 14(9): 1015 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. M. Karjalainen, R. H. Tammi, M. I. Tammi, M. J. Eskelinen, U. M. Agren, J. J. Parkkinen, E. M. Alhava, and V.-M. Kosma
Reduced Level of CD44 and Hyaluronan Associated with Unfavorable Prognosis in Clinical Stage I Cutaneous Melanoma
Am. J. Pathol., September 1, 2000; 157(3): 957 - 965.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Drillenburg and S. T. Pals
Cell adhesion receptors in lymphoma dissemination
Blood, March 15, 2000; 95(6): 1900 - 1910.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Jones, L. Tussey, N. Athanasou, and D. G. Jackson
Heparan Sulfate Proteoglycan Isoforms of the CD44 Hyaluronan Receptor Induced in Human Inflammatory Macrophages Can Function as Paracrine Regulators of Fibroblast Growth Factor Action
J. Biol. Chem., March 10, 2000; 275(11): 7964 - 7974.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Anttila, R. H. Tammi, M. I. Tammi, K. J. Syrjänen, S. V. Saarikoski, and V.-M. Kosma
High Levels of Stromal Hyaluronan Predict Poor Disease Outcome in Epithelial Ovarian Cancer
Cancer Res., January 1, 2000; 60(1): 150 - 155.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
A.-L. Tuhkanen, U. M. Ågren, M. I. Tammi, and R. H. Tammi
CD44 Expression Marks the Onset of Keratinocyte Stratification and Mesenchymal Maturation into Fibrous Dermis in Fetal Human Skin
J. Histochem. Cytochem., December 1, 1999; 47(12): 1617 - 1624.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
E. Ruijter, C. van de Kaa, G. Miller, D. Ruiter, F. Debruyne, and J. Schalken
Molecular Genetics and Epidemiology of Prostate Carcinoma
Endocr. Rev., February 1, 1999; 20(1): 22 - 45.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
N. Ohta, H. Saito, T. Kuzumaki, T. Takahashi, M.M. Ito, T. Saito, K. Nakahara, and M. Hiroi
Expression of CD44 in human cumulus and mural granulosa cells of individual patients in in-vitro fertilization programmes
Mol. Hum. Reprod., January 1, 1999; 5(1): 22 - 28.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J SPENCER
Differentiating ulcerative colitis from Crohn's disease: false dawn for CD44
Gut, September 1, 1998; 43(3): 310 - 311.
[Full Text]


Home page
GutHome page
W Reinisch, K-H Heider, G Oberhuber, C Dejaco, M Mullner, G R Adolf, and C Gasche
Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease
Gut, September 1, 1998; 43(3): 375 - 382.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C. Claas, S. Seiter, A. Claas, L. Savelyeva, M. Schwab, and M. Zoller
Association Between the Rat Homologue of CO-029, a Metastasis-associated Tetraspanin Molecule and Consumption Coagulopathy
J. Cell Biol., April 6, 1998; 141(1): 267 - 280.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Kogerman, M.-S. Sy, and L. A. Culp
Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: Facilitated retention in the lung vasculature
PNAS, November 25, 1997; 94(24): 13233 - 13238.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Schmits, J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al.
CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity
Blood, September 15, 1997; 90(6): 2217 - 2233.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
S.-N. Zhu, B. Nolle, and G. Duncker
Expression of adhesion molecule CD44 on human corneas
Br J Ophthalmol, January 1, 1997; 81(1): 80 - 84.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
M. F. Spafford, J. Koeppe, Z. Pan, P. G. Archer, A. D. Meyers, and W. A. Franklin
Correlation of Tumor Markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 With Survival and Metastasis in Laryngeal Squamous Cell Carcinoma
Arch Otolaryngol Head Neck Surg, June 1, 1996; 122(6): 627 - 632.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
K. Takahashi, I. Stamenkovic, M. Cutler, A. Dasgupta, and K. K. Tanabe
Keratan Sulfate Modification of CD44 Modulates Adhesion to Hyaluronate
J. Biol. Chem., April 19, 1996; 271(16): 9490 - 9496.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. E. I. Taher, L. Smit, A. W. Griffioen, E. J. M. Schilder-Tol, J. Borst, and S. T. Pals
Signaling through CD44 Is Mediated by Tyrosine Kinases
J. Biol. Chem., February 2, 1996; 271(5): 2863 - 2867.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Nath, P. A. van der Merwe, Sør. Kelm, P. Bradfield, and P. R. Crocker
The Amino-terminal Immunoglobulin-like Domain of Sialoadhesin Contains the Sialic Acid Binding Site
J. Biol. Chem., November 3, 1995; 270(44): 26184 - 26191.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. Hudson, J Sleeman, and F. Watt
CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion
J. Cell Sci., January 5, 1995; 108(5): 1959 - 1970.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.